Use and application of organ-on-a-chip platforms in cancer research

Area of Science:

• Biomedical Engineering
• Oncology
• Microfluidics

Background:

• Tumors are a leading global cause of death, necessitating improved anti-tumor therapies.
• Current in vitro and in vivo tumor models fail to accurately replicate critical cancer features.
• Organ-on-a-chip technology integrates organoids, microfluidics, and tissue engineering to mimic tumor physiology.

Purpose of the Study:

• To review the development of organ-on-a-chip technology for cancer research.
• To discuss the application of these models in basic and clinical oncology.
• To summarize advancements in cancer research enabled by organ-on-a-chip systems.

Main Methods:

• Literature review of organ-on-a-chip development in cancer research.
• Analysis of how organ-on-a-chip models mimic tumor microenvironments.
• Exploration of high-throughput screening capabilities of microfluidic organ-on-a-chip platforms.

Main Results:

• Organ-on-a-chip models provide 3D in vitro human tumor environments with multiple cell types and structures similar to primary tumors.
• These models can be applied across various oncology research areas.
• Microfluidic organ-on-a-chip technology enables large-scale drug screening and personalized medicine development.

Conclusions:

• Organ-on-a-chip technology represents an innovative tool for cancer research.
• These advanced models enhance the study of tumor physiology and anti-tumor therapies.
• The technology holds significant promise for accelerating drug discovery and tailoring treatments for cancer patients.